Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis

COVID-19 patients are at high risk for both capillary micro thrombi and large vessel thrombosis. Anticoagulant administration in COVID-19 patients, especially in ICU setting, is recommended by some researchers. However, clinical guidelines don't yet recommend anticoagulation therapies in therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Javid, Amir, Kazemi, Reza, Dehghani, Mehdi, Bahrami Samani, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Inflammation and Infection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829136/
https://www.ncbi.nlm.nih.gov/pubmed/33520659
http://dx.doi.org/10.1016/j.eucr.2021.101568
_version_ 1783641125844680704
author Javid, Amir
Kazemi, Reza
Dehghani, Mehdi
Bahrami Samani, Hossein
author_facet Javid, Amir
Kazemi, Reza
Dehghani, Mehdi
Bahrami Samani, Hossein
author_sort Javid, Amir
collection PubMed
description COVID-19 patients are at high risk for both capillary micro thrombi and large vessel thrombosis. Anticoagulant administration in COVID-19 patients, especially in ICU setting, is recommended by some researchers. However, clinical guidelines don't yet recommend anticoagulation therapies in therapeutic doses in these patients. In this article, we try to introduce a less known complication of heparin application in COVID-19 patients. Retroperitoneal hemorrhage when involves the psoas muscle might be deadly because of the large volume of bleeding before causing any significant alarm. It is very important to be careful in diagnosing and managing this complication.
format Online
Article
Text
id pubmed-7829136
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78291362021-01-26 Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis Javid, Amir Kazemi, Reza Dehghani, Mehdi Bahrami Samani, Hossein Urol Case Rep Inflammation and Infection COVID-19 patients are at high risk for both capillary micro thrombi and large vessel thrombosis. Anticoagulant administration in COVID-19 patients, especially in ICU setting, is recommended by some researchers. However, clinical guidelines don't yet recommend anticoagulation therapies in therapeutic doses in these patients. In this article, we try to introduce a less known complication of heparin application in COVID-19 patients. Retroperitoneal hemorrhage when involves the psoas muscle might be deadly because of the large volume of bleeding before causing any significant alarm. It is very important to be careful in diagnosing and managing this complication. Elsevier 2021-01-13 /pmc/articles/PMC7829136/ /pubmed/33520659 http://dx.doi.org/10.1016/j.eucr.2021.101568 Text en © 2021 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Inflammation and Infection
Javid, Amir
Kazemi, Reza
Dehghani, Mehdi
Bahrami Samani, Hossein
Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis
title Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis
title_full Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis
title_fullStr Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis
title_full_unstemmed Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis
title_short Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis
title_sort catastrophic retroperitoneal hemorrhage in covid-19 patients under anticoagulant prophylaxis
topic Inflammation and Infection
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829136/
https://www.ncbi.nlm.nih.gov/pubmed/33520659
http://dx.doi.org/10.1016/j.eucr.2021.101568
work_keys_str_mv AT javidamir catastrophicretroperitonealhemorrhageincovid19patientsunderanticoagulantprophylaxis
AT kazemireza catastrophicretroperitonealhemorrhageincovid19patientsunderanticoagulantprophylaxis
AT dehghanimehdi catastrophicretroperitonealhemorrhageincovid19patientsunderanticoagulantprophylaxis
AT bahramisamanihossein catastrophicretroperitonealhemorrhageincovid19patientsunderanticoagulantprophylaxis

Ejemplares similares